1h Free Analyst Time
The publisher has been monitoring the injectable drug delivery devices market and it is poised to grow by $22.29 bn during 2022-2026, progressing at a CAGR of 8.48% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases and growth in the biologics market.
The injectable drug delivery devices market analysis includes the type segment and geographic landscape.
The injectable drug delivery devices market is segmented as below:
By Type
- Advanced injectable drug delivery devices
- Conventional injectable drug delivery devices
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies digitalization in the healthcare system as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years.
The report on injectable drug delivery devices market covers the following areas:
- Injectable drug delivery devices market sizing
- Injectable drug delivery devices market forecast
- Injectable drug delivery devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injectable drug delivery devices market vendors that include AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Eli Lilly and Co., Gerresheimer AG, Owen Mumford Ltd., Sanofi SA, SCHOTT AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the injectable drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Advanced injectable drug delivery devices - Market size and forecast 2021-2026
- Conventional injectable drug delivery devices - Market size and forecast 2021-2026
- Market opportunity by Type
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive landscape
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc
- Baxter International Inc.
- Becton Dickinson and Co.
- Eli Lilly and Co.
- Gerresheimer AG
- Owen Mumford Ltd.
- Sanofi SA
- SCHOTT AG
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Type - Market share 2021-2026 (%)
- Comparison by Type
- Advanced injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
- Advanced injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
- Conventional injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
- Conventional injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
- Market opportunity by Type
- Customer landscape
- Market share by geography 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity by geography ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product and service
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Key customers
- AstraZeneca Plc - Segment focus
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Key customers
- Baxter International Inc. - Segment focus
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Key customers
- Becton Dickinson and Co. - Segment focus
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Business segments
- Eli Lilly and Co. - Key offerings
- Eli Lilly and Co. - Key customers
- Eli Lilly and Co. - Segment focus
- Gerresheimer AG - Overview
- Gerresheimer AG - Business segments
- Gerresheimer AG - Key offerings
- Gerresheimer AG - Key customers
- Gerresheimer AG - Segment focus
- Owen Mumford Ltd. - Overview
- Owen Mumford Ltd. - Product and service
- Owen Mumford Ltd. - Key offerings
- Owen Mumford Ltd. - Key customers
- Owen Mumford Ltd. - Segment focus
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key offerings
- Sanofi SA - Key customers
- Sanofi SA - Segment focus
- SCHOTT AG - Overview
- SCHOTT AG - Business segments
- SCHOTT AG - Key offerings
- SCHOTT AG - Key customers
- SCHOTT AG - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key offerings
- Viatris Inc. - Key customers
- Viatris Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global injectable drug delivery devices market: AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Eli Lilly and Co., Gerresheimer AG, Owen Mumford Ltd., Sanofi SA, SCHOTT AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is digitalization in the healthcare system.'
According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Baxter International Inc.
- Becton Dickinson and Co.
- Eli Lilly and Co.
- Gerresheimer AG
- Owen Mumford Ltd.
- Sanofi SA
- SCHOTT AG
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
